Where are we with MRD assessment in CLL management?


On behalf of the Scientific Committee, you are invited to join us for this LIVE interactive broadcast.

Professor Paolo Ghia and Dr Andrew Rawstron will discuss minimal residual disease (MRD) assessment in CLL with particular focus on:

•    How to measure MRD and the interpretation of results
•    The impact that MRD assessment could have on the clinical management of CLL patients
•    Whether MRD assessment in CLL currently has a place in clinical practice

During the live broadcast you will have the opportunity to ask questions and interact with the faculty.

Please REGISTER now for the live broadcast and to enable access to the on-demand version.


Learning objective:

After participating in this broadcast you should be able to:

  • Evaluate the role of MRD assessment in the management of patients with CLL



  • Paolo Ghia (Italy)
  • Andrew Rawstron (UK)

More Info
44 Minutes
EM-49349 - Date of preparation: February 2021